Canada's Weston Family Acquires Boots in $8.9bn Landmark Deal 2026

The Canadian Weston family has acquired Boots, the UK pharmacy and beauty retailer, for $8.9bn (£6.74bn), in a landmark deal that reshapes the British high street. Wittington Investments, the family's holding company, will take ownership of Boots' UK and Irish retail operations, its opticians chain, the No7 beauty brand, and a franchise arm in Thailand.

Who Are the Weston Family and Why Boots?

The Weston family is one of Canada's wealthiest and most established retail dynasties. They control Loblaws, Canada's largest grocery chain, and Shoppers Drug Mart, a leading pharmacy chain. This acquisition marks a return to UK retail for the family, who previously owned Selfridges department store.

Galen Weston, chair of Wittington Investments, said: "Boots is one of Britain's most enduring businesses, with a rich heritage, a trusted name and a vital role in everyday life across the UK and Ireland." He added that the family sees "a meaningful opportunity to make a great business even better through stable long-term ownership, further capital investment, and the renewed operating focus required to serve customers with excellence for generations to come."

Details of the $8.9bn Acquisition

The deal includes Boots' 1,800 UK stores, which employ 50,000 people, as well as its opticians chain and the No7 beauty brand. The acquisition is backed by Fairfax, an investment firm that owns The Sporting Life Group and Sleep Country, Canada's largest mattress retailer (which owns Simba Sleep in the UK).

The transaction sees the exit of Boots' long-term backer Stefano Pessina and his latest backer, Sycamore Partners. It is subject to regulatory approval and is expected to close in the first quarter of 2025.

What This Means for the UK Retail Landscape

Boots is a staple of UK high streets, with a strong presence in pharmacy, health and beauty. The Weston family's ownership could bring stability and investment, especially after years of changing ownership. The deal may also lead to synergies with the family's Canadian pharmacy operations, potentially improving efficiency and product offerings.

However, challenges remain. The UK pharmacy sector faces pressures from online competitors, regulatory changes, and shifting consumer habits. The Weston family's experience in drug retail could help Boots navigate these issues.

Comparison: Boots vs. Other UK Pharmacy Chains

Key Takeaways from the Boots Acquisition

• Weston family returns to UK retail after selling Selfridges in 2022.
• Deal valued at $8.9bn, backed by Fairfax and Wittington Investments.
• Boots' 1,800 stores and 50,000 employees will remain under new ownership.
• Stefano Pessina and Sycamore Partners exit after years of involvement.
• Regulatory approval expected by Q1 2025.

FAQ